Streptococcus pyogenes (group A streptococcus) causes human skin and throat infections as well as highly invasive diseases including necrotising fasciitis. Group A streptococcal infections and invasive disease have made a resurgence in developed countries over the last two decades. S. pyogenes utilise multiple pathways for the acquisition and activation of human plasminogen, securing potent proteolytic activity on the bacterial cell surface. Recent experimental evidence using a humanised transgenic mouse model suggests a critical role for human plasminogen in the dissemination of S. pyogenes in vivo.
S. pyogenes strains of M1T1 and M3 serotypes can be isolated from both uncomplicated infections such as pharyngitis and severe invasive infections such as necrotising fasciitis [5, 13] .
These group A streptococcal strains can also vary greatly in disease frequency and exhibit epidemic behaviour suggesting these strains are capable of rapid genetic change. Beres et al. [14] found that the major generator of distinct genotypes within 255 group A streptococcal strains (serotype M3) was the acquisition and loss of prophages encoding known and putative virulence factors. This molecular process combined with altered immune recognition due to a four amino acid change in the N-terminal region of the M protein is believed to have significantly contributed to an epidemic wave of M3 invasive infections [14] . Phage sequences present in the two sequenced M3 genomes have also been detected in the genome of S. pyogenes M1T1, a strain that is often isolated from invasive diseases [15] . The genetic mosaicism and unique gene sequences present in these phage cassettes act as additional sources of genetic variability and suggest phages can be shared between different M serotypes and even different bacterial species [15] . Host genetic factors have also been shown to play an important role in determining the severity of invasive group A streptococcal infections by altering the magnitude of the cytokine and inflammatory responses against secreted streptococcal pyrogenic exotoxins [16, 17] .
Common to all invasive group A streptococcal diseases is the requirement of the bacteria to gain entry into areas of the body that are normally sterile sites. Plasminogen binding and its activation to the broad-spectrum serine protease plasmin has been implicated as a contributing mechanism of invasion for S. pyogenes and a variety of other bacterial species [18, 19] .
Binding of plasminogen to the group A streptococcal cell surface:
Plasminogen is the multidomain, 791 amino acid circulating zymogen form of plasmin. Plasminogen contains five kringle domains with lysine-binding sites identified in kringles 1, 2, 4 and 5 which are responsible for binding to fibrinogen and plasminogen receptors [20] . Two pathways have been described in the literature for the binding of plasminogen to the group A streptococcal cell surface. Direct plasminogen binding is meditated by the three known surface plasminogen receptors: plasminogen-binding group A streptococcal M-like protein (PAM or M53; [21] ), αenolase (surface enolase or SEN; [22] ) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), alternatively known either as plasminogen receptor (Plr) or streptococcal surface dehydrogenase (SDH) [22, 23] . Additionally, indirect binding of plasminogen is mediated by the formation of a trimolecular complex consisting of plasminogen, streptokinase and fibrinogen.
This complex is then bound to the group A streptococcal cell surface via either plasminogen or fibrinogen receptors [24] [25] [26] .
Of the three known plasminogen receptors, published evidence suggests that PAM makes the largest contribution to direct plasminogen binding by group A streptococci. In two independent studies, PAM-positive S. pyogenes isolates have been found to bind significantly higher levels of plasminogen than PAM-negative isolates [26, 27] (Figure 1A) . Svensson et al. [27] found an association between PAM-positive isolates and impetigo. Nonetheless, in a study of group A streptococcal isolates from the Northern Territory of Australia where skin infections are endemic, PAM-positive isolates were found to cause bacteremia, throat and skin infections [26] .
Binding of PAM to plasminogen is mediated by amino-terminal plasminogen-binding tandem repeat motifs containing lysine residues (designated a1 and a2) in the PAM molecule, which interact with the lysine binding kringle 2 domain of plasminogen [21, 28, 29] .
Plasminogen has been reported to bind to cell-surface located glycolytic enzymes α-enolase and GAPDH [22, 23] . Both GAPDH and α-enolase interact with lysine binding kringles domain of plasminogen via carboxy-terminal lysine residues [22, 30] . Such carboxy-terminal lysine residues usually bind to kringle 1, 4 and 5 of plasminogen [20] . Whilst α-enolase has been described as a high affinity plasminogen receptor [22] , the failure of PAM-negative isolates to bind significant levels of plasminogen by the direct binding pathway [26, 27] suggests that α-enolase may play a more prominent role in the indirect binding pathway by interacting with a trimolecular complex consisting of plasminogen, streptokinase and fibrinogen ( Figure 1A ). GAPDH has been reported to bind plasminogen with low affinity [22] . Neither GAPDH nor α-enolase contain known secretion signals or membrane anchor motifs and the mechanism by which these glycolytic enzymes become surface exposed is unknown. Both enzymes have also been detected in S. pyogenes culture supernatants [31, 32] . Other researchers have suggested hypotheses to account for cell-surface GAPDH and α-enolase including the release of such proteins from group A streptococcal cells by autolysis with the released protein potentially binding back to the surface of neighbouring cells or the existence of a hitherto uncharacterised transport mechanism [22, 33] .
Recently, asymmetric protein secretion of streptococcal pyrogenic exotoxin B (SpeB) was shown to occur at distinct cytoplasmic membrane microdomains termed ExPortals [34] . The role that this structure plays in the secretion of other S. pyogenes proteins is currently unknown. However, GAPDH and α-enolase are also asymmetrically distributed on the GAS cell surface [22, 33, 35] , reminiscent of the distribution of SpeB at the GAS ExPortal ( Figure 2 ). We therefore hypothesise that both GAPDH and α-enolase are secreted from the group A streptococcal cell via the ExPortal then subsequently bind to the cell surface.
As mentioned above, the indirect plasminogen-binding pathway in S. pyogenes requires streptokinase and fibrinogen [24, 25, 36] (Figure 1A ). Takada and Takada [36] first reported the capacity of plasminogen, fibrinogen and streptokinase to form a trimolecular complex. This complex, which forms extracellularly then binds to the surface of group A streptococci, possesses both plasmin [25] and plasminogen-activator [37] activities. This pathway may represent the primary plasminogen surface-acquisition mechanism in PAM-negative S. pyogenes isolates.
Acquisition of surface plasmin:
The conversion of plasminogen to plasmin can be achieved by either the mammalian plasminogen activators urokinase (uPA) and tissue plasminogen activator (tPA), or by secreted microbial activators such as streptokinase [19, 20] . As distinct from tPA or uPA, which directly cleave the plasminogen activation bond (i.e. Arg561-Val562) to generate plasmin, streptokinase has no protease activity and cannot directly cleave this bond. Instead, streptokinase forms a 1:1 complex with plasminogen. The preferred catalytic substrate of this complex is the activation loop of other plasminogen molecules [38] . Plasminogen bound to the group A streptococcal surface can also interact with streptokinase leading to bacterium bound plasmin activity [25, 37, 39] . Additionally, tPA and uPA have been shown to activate plasminogen bound to the group A streptococcal surface [21, 40] ( Figure 3A) . The streptokinaseplasminogen activator complex and surface-bound plasmin cannot be inhibited by host plasmin inhibitors (i.e. α2-antiplasmin and α2-macroglobulin) [19, 41] . This suggests a propensity of S. pyogenes for unregulated plasminogen activation capacity and plasmin activity regardless of host inhibitors.
However, Tewodros et al. [42] found no correlation between secreted streptokinase activity in vitro and disease manifestation. Furthermore, high plasminogen binding strains were found to secrete low levels of streptokinase activity [42] ( Figure 1B ). Phylogenetic analysis of the βdomain region of the gene encoding streptokinase (ska) revealed 2 major sequence clusters Figure 1B ). An alternative explanation for these observations may be related to the various ska alleles. Kalia and Bessen [43] proposed that subcluster 2b forms of streptokinase have adapted for interaction with plasminogen in the open conformation induced by binding to PAM rather than the closed circulating form of plasminogen (i.e. in solution phase) preferred by the other subcluster forms of streptokinase ( Figure 3B and 3C, respectively). Thus, if subcluster 2b forms of streptokinase can only form streptokinase-plasminogen activator complexes when surface bound to PAM, this may account for the apparent lack of streptokinase activity in the supernatants of PAM-positive strains ( Figure 1B ). Non-cluster 2b forms of streptokinase may interact with both free and surface-bound forms of plasminogen ( Figure 3C ). Even in the absence of streptokinase, the ability to focus plasminogen at the group A streptococcal surface via cell-surface receptors enhances virulence in vivo. A streptokinasedeficient S. pyogenes strain with plasminogen-binding capacity showed enhanced virulence when a human plasminogen source was provided, probably due to plasmin formation by host activators, tPA or uPA [48] . Human plasminogen is more readily activated by murine tPA than is murine plasminogen [46] . The binding of plasminogen to S. pyogenes is known to markedly increase the rate of plasminogen activation by tPA [40] supporting the hypothesis that cellsurface binding of plasminogen is an important component of group A streptococcal pathogenesis. 
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